Protective effect of truncated Na+/K+‐ATPase β on ischemia/reperfusion-induced renal injury in rats

Abstract

Renal ischemia/reperfusion(I/R) is an important injury part of ischemic acute renal failure, and it is also the main factor that affects the early functional recovery and the long-term survival of transplanted kidney in renal transplantation. In this study, we cloned and expressed truncated Na+/K+‐ATPase β(tNKAβ) and demonstrated that tNKAβ could activate NKA α subunit and induce protective effect on human kidney-2(HK-2) cells via PKCɛ signal pathway. The half maximum effective concentrations (EC₅₀) of tNKAβ were 0.24 µM. Furthermore, the application of EAVSLKPT (PKCɛ inhibitor) could abolish the protective effect of tNKAβ in HK-2 cells subjected to ischemia/reperfusion. To identify the protective effect of tNKAβ against the I/R injury in the kidney, Sprague-Dawley rats were treated with tNKAβ (75 mg/kg) for 2 h before ischemia. The tNKAβ-treated group demonstrated a significant improvement in renal function with a lower serum creatinine and blood urea nitrogen (BUN) levels on postoperative days 1–6. Renal sections obtained from rats of the I/R group showed serious renal injury which included degeneration of tubular structure, tubular dilation, swelling and necrosis, luminal congestion, and muddy brown casts formed by sloughing of severely damaged tubular epithelial cells. However, sections of rats that were administered with tNKAβ 2 h before reperfusion showed marked reduction of the histological features of renal injury compared with kidneys that were subjected to I/R only. In conclusion, the protective effects of tNKAβ against renal I/R injury have been evaluated for the first time, and these protective effects may occur via stimulation of PKCɛ pathways.

Keywords

I/R AKF HK-2 cell tNKAβ PKCɛ

Get full access to this article

View all access options for this article.

References

Thadhani

Pascual

Bonventre

. Acute renal failure. N Engl J Med 1996; 334: 1448–60.

Bonventre

Weinberg

. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199–210.

Kaplan

. Biochemistry of Na,K-ATPase. Annu Rev Biochem 2002; 71: 511–35.

Liu

Tian

Haas

Shapiro

Askari

Xie

. Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem 2000; 275: 27838–44.

. Activation of (Na+ + K+)-ATPase. Biochem Biophys Res Commun 2005; 338: 1669–77.

Zheng

Koh

Hua

Larrick

Bian

. Cardioprotection induced by Na(+)/K(+)-ATPase activation involves extracellular signal-regulated kinase 1/2 and phosphoinositide 3-kinase/Akt pathway. Cardiovasc Res 2011; 89: 51–9.

Lee

Klein

Zhu

Xiao

Gerzanich

. Activation of (Na+ + K+)-ATPase modulates cardiac L-type Ca2+ channel function. Mol Pharmacol 2009; 75: 774–81.

Hasler

Crambert

Horisberger

Geering

. Structural and functional features of the transmembrane domain of the Na,K-ATPase beta subunit revealed by tryptophan scanning. J Biol Chem 2001; 276: 16356–64.

Ogawa

Shinoda

Cornelius

Toyoshima

. Crystal structure of the sodium-potassium pump (Na+,K+-ATPase) with bound potassium and ouabain. Proc Natl Acad Sci USA 2009; 106: 13742–7.

10.

Shinoda

Ogawa

Cornelius

Toyoshima

. Crystal structure of the sodium-potassium pump at 2.4 A resolution. Nature 2009; 459: 446–50.

11.

Rabb

Mendiola

Saba

Dietz

Smith

Bonventre

Ramirez

. Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury. Biochem Biophys Res Commun 1995; 211: 67–73.

12.

Mizutani

Okajima

Uchiba

Noguchi

. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 2000; 95: 3781–7.

13.

Kelly

Williams

Jr Colvin

Meehan

Springer

Gutierrez-Ramos

Bonventre

. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97: 1056–63.

14.

Thiemermann

Patel

Kvale

Cockerill

Brown

Stewart

Cuzzocrea

Britti

Mota-Filipe

Chatterjee

. High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury. J Am Soc Nephrol 2003; 14: 1833–43.

15.

Mejia-Vilet

Ramirez

Cruz

Uribe

Gamba

Bobadilla

. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol 2007; 293: F78–86.

16.

Weight

Bell

Nicholson

. Renal ischaemia–reperfusion injury. Br J Surg 1996; 83: 162–70.

17.

Bankir

Kriz

Goligorsky

Nambi

Thomson

Blantz

. Vascular contributions to pathogenesis of acute renal failure. Renal Fail 1998; 20: 663–77.

18.

Xie

Cai

. Na+-K+–ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv 2003; 3: 157–68.

19.

Dempsey

Newton

Mochly-Rosen

Fields

Reyland

Insel

Messing

. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 2000; 279: L429–38.

20.

Gutcher

Webb

Anderson

. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci 2003; 60: 1061–70.

21.

Griner

Kazanietz

. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 2007; 7: 281–94.

22.

Matsumura

Komori

Takusagawa

Osada

Tanabe

Itoh

Tamura

. Protein kinase C is involved in cardioprotective effects of ischemic preconditioning on infarct size and ventricular arrhythmia in rats in vivo. Mol Cell Biochem 2000; 214: 39–45.

23.

Moon

Jung

Lee

Baik

. Protein kinase C inhibitors abolish the increased resistance of diabetic rat heart to ischemia-reperfusion injury. Jpn J Physiol 1999; 49: 409–15.

24.

Geering

. Functional roles of Na,K-ATPase subunits. Curr Opin Nephrol Hypertens 2008; 17: 526–32.

25.

Cameron

Procyk

Leitges

Parker

. PKC alpha protein but not kinase activity is critical for glioma cell proliferation and survival. Int J Cancer 2008; 123: 769–79.

26.

Clark

West

Blumberg

Dennis

. Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance. Cancer Res 2003; 63: 780–6.